A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of study is to explore the effect of CP-690,550 (Tofacitinib) on measures of
kidney function in patients with active rheumatoid arthritis (RA).